Literature DB >> 8505640

Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection.

E Spargo1, I P Everall, P L Lantos.   

Abstract

The hippocampus is usually affected in primary dementias and the pathological changes may be severe. Knowledge of hippocampal pathology in HIV infection and Huntington's disease (HD), however, is extremely limited. A stereological technique (the optical "disector") has been used to assess neuronal populations in four areas of the hippocampus in 11 patients with HIV infection and in nine patients with HD. The HIV patients died without opportunistic infections or neoplasms affecting the brain; they had HIV encephalitis or minimal changes. The HD cases were all clinically diagnosed, had a positive family history and showed the characteristic lesions in the caudate nucleus. The neuronal counts were compared with those in nine controls. In the granule cell layer of the dentate, CA3 and CA4, there was no significant difference in the neuronal numerical density between the three groups. A striking difference between the HIV and HD groups was seen in the CA1 region. The neuronal numerical density in the CA1 area was significantly lower in the HD patients than in either the HIV patients or the controls (mean (SD) 37.5 (5.0); 70.1 (13.4); 57.9 (15.4) x 10(3) per mm3, p < 0.001 (Students' t test)). This difference represents a neuronal loss of 35%. In all four hippocampal areas the neuronal density was higher in the HIV group than in the controls but the differences were not significant and can be explained by the higher average age of the control group. These findings contribute to the understanding of the mechanism of dementia in both AIDS and in Huntington's disease.

Entities:  

Mesh:

Year:  1993        PMID: 8505640      PMCID: PMC1015006          DOI: 10.1136/jnnp.56.5.487

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

Review 1.  Neuropathology of human immunodeficiency virus infection.

Authors:  H Budka
Journal:  Brain Pathol       Date:  1991-04       Impact factor: 6.508

2.  Excitotoxic models for neurodegenerative disorders.

Authors:  R Schwarcz; A C Foster; E D French; W O Whetsell; C Köhler
Journal:  Life Sci       Date:  1984-07-02       Impact factor: 5.037

3.  Automated differential cell counting on a sector of the normal human hippocampus: the influence of age.

Authors:  A K Miller; R L Alston; C Q Mountjoy; J A Corsellis
Journal:  Neuropathol Appl Neurobiol       Date:  1984 Mar-Apr       Impact factor: 8.090

4.  The unbiased estimation of number and sizes of arbitrary particles using the disector.

Authors:  D C Sterio
Journal:  J Microsc       Date:  1984-05       Impact factor: 1.758

5.  The AIDS dementia complex: II. Neuropathology.

Authors:  B A Navia; E S Cho; C K Petito; R W Price
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

6.  Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients. A quantitative study.

Authors:  M J Ball
Journal:  Acta Neuropathol       Date:  1978-05-24       Impact factor: 17.088

7.  Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases.

Authors:  H Budka; G Costanzi; S Cristina; A Lechi; C Parravicini; R Trabattoni; L Vago
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

8.  Periventricular white matter changes and dementia. Clinical, neuropsychological, radiological, and pathological correlation.

Authors:  S R Gupta; M H Naheedy; J C Young; M Ghobrial; F A Rubino; W Hindo
Journal:  Arch Neurol       Date:  1988-06

9.  Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients.

Authors:  W D Snider; D M Simpson; S Nielsen; J W Gold; C E Metroka; J B Posner
Journal:  Ann Neurol       Date:  1983-10       Impact factor: 10.422

10.  Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease.

Authors:  E D London; H I Yamamura; E D Bird; J T Coyle
Journal:  Biol Psychiatry       Date:  1981-02       Impact factor: 13.382

View more
  43 in total

1.  Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.

Authors:  P H Reddy; V Charles; M Williams; G Miller; W O Whetsell; D A Tagle
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Diffusion-tensor MR imaging of the brain in human immunodeficiency virus-positive patients.

Authors:  Majda M Thurnher; Mauricio Castillo; Alfred Stadler; Armin Rieger; Brigitte Schmid; Pia C Sundgren
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

3.  Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia.

Authors:  Jadwiga Turchan-Cholewo; Filomena O Dimayuga; Qunxing Ding; Jeffrey N Keller; Kurt F Hauser; Pamela E Knapp; Annadora J Bruce-Keller
Journal:  J Neurosci Res       Date:  2008-07       Impact factor: 4.164

4.  Intrajugular vein delivery of AAV9-RNAi prevents neuropathological changes and weight loss in Huntington's disease mice.

Authors:  Brett D Dufour; Catherine A Smith; Randall L Clark; Timothy R Walker; Jodi L McBride
Journal:  Mol Ther       Date:  2014-01-06       Impact factor: 11.454

5.  Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease.

Authors:  Paula A Desplats; James R Lambert; Elizabeth A Thomas
Journal:  Neurobiol Dis       Date:  2008-05-22       Impact factor: 5.996

Review 6.  Huntington's disease: the coming of age.

Authors:  Mritunjay Pandey; Usha Rajamma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

7.  Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington's disease.

Authors:  Maria Manczak; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2015-10-12       Impact factor: 6.150

Review 8.  The role of dopamine in Huntington's disease.

Authors:  Carlos Cepeda; Kerry P S Murphy; Martin Parent; Michael S Levine
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

9.  Soluble N-terminal fragment of mutant Huntingtin protein impairs mitochondrial axonal transport in cultured hippocampal neurons.

Authors:  Jun Tian; Ya-Ping Yan; Rui Zhou; Hui-Fang Lou; Ye Rong; Bao-Rong Zhang
Journal:  Neurosci Bull       Date:  2013-12-21       Impact factor: 5.203

10.  Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6/1 mouse model of Huntington's disease.

Authors:  Marta Anglada-Huguet; Xavier Xifró; Albert Giralt; Alfonsa Zamora-Moratalla; Eduardo D Martín; Jordi Alberch
Journal:  Mol Neurobiol       Date:  2013-11-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.